Details for 2020704633
Up to date per 11.04.2026
Actions
Details for 2020704633
Granted/Registered
European Patent
10.11.2021 A
01.11.2023 B1
04.01.2019
US
201962788324 P
16.04.2019
US
201962834830 P
A61K 48/00 20030101AFI20200710BHEP
Owner
Ultragenyx Pharmaceutical Inc.60 Leveroni Court Novato, CA 94949US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
LIVINGSTON, Christine Novato, CA 94949US
WADSWORTH, Samuel Novato, CA 94949US
Information about Fees